EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics

Xuan Zhong, Jingru Guo, Xiuping Han, Wenyu Wu, Rui Yang, Jun Zhang iD, Guoqiang Shao

Molecular Pharmaceutics · 01.05.2023 · 20 (5) · 2402-2414

DOI: 10.1021/acs.molpharmaceut.2c00965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.04.2023. Verfasst von Xuan Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing University of Chinese Medicine, Nanjing 210046, China. Hauptthemen laut MEDLINE: Neoplasms, Quinolines. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Jiangsu Provincial Medical Youth Talent, Taizhou Municipal Science and Technology Bureau, Six Talent Peaks Project in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsQuinolinesHumansPrecision MedicineGallium RadioisotopesPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

FAP inhibitorfibroblast activation proteinmicro-PETtheranostics

Substanzen

68Ga-FAPIGallium RadioisotopesQuinolines

Autor:innen und Institutionen

  • Nanjing University of Chinese Medicine, Nanjing 210046, China.
  • Department of Nuclear Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou 225300, China.
  • Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009, China.
  • Department of Nuclear Medicine, Nanjing Medical University Affiliated Nanjing Hospital, Nanjing 210029, China.

ORCID-Profile: Jun Zhang

Förderung

  • Jiangsu Provincial Medical Youth Talent
  • Taizhou Municipal Science and Technology Bureau
  • Six Talent Peaks Project in Jiangsu Province
  • Nanjing Medical Science and Technique Development Foundation

Zitieren

APA

Zhong, X., Guo, J., Han, X., Wu, W., Yang, R., Zhang, J., & Shao, G. (2023). Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics. Molecular Pharmaceutics, 20(5), 2402-2414. https://doi.org/10.1021/acs.molpharmaceut.2c00965

Vancouver

Zhong X, Guo J, Han X, Wu W, Yang R, Zhang J, et al. Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics. Molecular Pharmaceutics. 2023;20(5):2402-2414. doi:10.1021/acs.molpharmaceut.2c00965

BibTeX
@article{Zhong2023,
  author = {Zhong, Xuan and Guo, Jingru and Han, Xiuping and Wu, Wenyu and Yang, Rui and Zhang, Jun and Shao, Guoqiang},
  title = {Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {5},
  pages = {2402--2414},
  doi = {10.1021/acs.molpharmaceut.2c00965}
}
Kostenlos starten →